Keyword: GlaxoSmithKline (GSK)
News
18.12.2015
- US biopharmaceutical group Amgen is buying back from GlaxoSmithKline (GSK) all of its remaining rights to the bone drugs Prolia (denosumab), Xgeva (denosumab) and Vectibix...
News
06.11.2015
- GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...
News
22.10.2015
- Six international drugmakers, led by GlaxoSmithKline (GSK) and including Johnson & Johnson, Biogen, Eli Lilly, Pfizer and Takeda, have joined forces with the UK Department of...
News
13.10.2015
- Israeli generics giant Teva Pharmaceutical Industries has launched a generic equivalent to Glaxo SmithKline’s Avodart (dutasteride) 0.5 mg capsules on the US market. The active...
Markets & Companies
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
Markets & Companies
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
Strategy & Management
07.10.2015
- Allotrope Foundation, an international consortium of pharmaceutical and biopharmaceutical companies with a common vision to develop innovative new approaches for handling data in R...
News
25.09.2015
- Following the green light from health regulator European Medicines Agency, the European Commission is expected to decide on a final approval for GlaxoSmithKline’s (GSK) injectable...
